Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#How Much Is the Global Genetic Mutation Analysis Market Valued at Present and by 2029?#_x000D_
Over the past few years, there’s been swift expansion in the genetic mutation analysis market. It’s anticipated to grow from a value of $5.94 billion in 2024 to $6.65 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.9%. The growth witnessed in the historic period can be associated with the rise in the number of genetic disorders and inherited diseases, increased recognition of the benefits of personalized medicine, advancements in sequencing technologies, higher usage of liquid biopsy techniques, and the enhanced integration of AI and big data analytics._x000D_
_x000D_
The market for genetic mutation analysis is anticipated to experience rapid expansion in the coming years. It’s projected to escalate to a value of $10.30 billion by 2029, with a compound annual growth rate (CAGR) of 11.5%. The expected growth within this forecast period can be credited to several factors like increased government initiatives and funding towards genomics research, a surge in the demand for early detection and preventive testing of diseases, wider access to direct-to-consumer (DTC) genetic testing, an increased requirement in oncology and infectious disease tracking, plus a growing interest in reproductive and prenatal genomic applications. During the forecast period, the market trend will be majorly driven by developments in sequencing technologies, the introduction of AI and bioinformatics tools, advancements in detecting rare mutations, improvements in lab-on-a-chip and microfluidic technologies, and the integration of accelerated computing._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=27297&type=smp_x000D_
_x000D_
#What Drivers Are Influencing Growth In The Genetic Mutation Analysis Market?_x000D_
The increasing occurrence of genetic diseases is anticipated to boost the development of the genetic mutation analysis market in the future. Genetic diseases are conditions triggered by anomalies or genetic mutations within an individual’s DNA that can either be hereditary or occur spontaneously. The heightened frequency of genetic diseases is partially attributed to older parental age, which elevates the likelihood of genetic mutations during conception, thereby increasing the potential for these conditions in their offspring. Genetic mutation analyses can identify changes in genes that can bring about or indicate the existence of genetic diseases, allowing for early detection, precise treatment, and well-informed reproductive or lifestyle choices. For instance, the Cystic Fibrosis Trust, a UK-based charity devoted to aiding individuals with cystic fibrosis, reported that in October 2024, the number of registered patients rose from 11,148 in 2022 to 11,318 in 2023, marking a 1.5% annual increase in patient registrations. Thus, the escalating incidence of genetic diseases is fueling the expansion of the genetic mutation analysis market._x000D_
_x000D_
#What Are The Main Segments Identified In The Genetic Mutation Analysis Market Research?#_x000D_
The genetic mutation analysis market covered in this report is segmented_x000D_
_x000D_
1) By Component: Hardware, Software, Services_x000D_
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)_x000D_
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics_x000D_
4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories_x000D_
_x000D_
Subsegment:_x000D_
1) By Hardware: Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems_x000D_
2) By Software: Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools_x000D_
3) By Services: Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services_x000D_
_x000D_
#What Are The Leading Trends And Opportunities In The Genetic Mutation Analysis Sector?#_x000D_
Leading businesses in the genetic mutation analysis market are concentrating on the invention of novel solutions such as tissue-oriented next-generation sequencing (NGS) exams, with an aim to improve accuracy in detecting actionable genetic changes and guiding individualized treatment plans. Tissue-oriented next-generation sequencing (NGS) exams serve as sophisticated diagnostic instruments that scrutinize DNA or RNA from a tissue specimen to identify genetic mutations, changes, or disease-related biomarkers such as cancer. For example, the US-based oncology firm Guardant Health Inc. introduced the Guardant360 TissueNext test in June 2024, increasing the gene detection in a tumor tissue specimen to 498. These genes or cancer biomarkers allow oncologists to discern the most effective targeted therapies or treatment plans for patients suffering from advanced cancer. In addition to extending the panel, Guardant has improved the test’s operational efficiency for quicker turnover times. The novel Guardant360 TissueNext test will be exclusively offered to Medicare fee-for-service patients with advanced solid tumor cancers, following the cover granted by Palmetto GBA, a Medicare administrative agency for the Molecular Diagnostics Services initiative (MolDX), under the existing local coverage decision._x000D_
_x000D_
#Which Companies Play A Key Role In The Development Of The Genetic Mutation Analysis Market?#_x000D_
Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, and BGI Genomics Co. Ltd. _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
_x000D_
#What Are The Key Regional Developments Shaping The Genetic Mutation Analysis Market?#_x000D_
North America was the largest region in the genetic mutation analysis market in 2024. The regions covered in the genetic mutation analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=27297&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model